1mg, best e pharmacy in India

OCUNAP EYE DROP

generic_icon
MRP: Rs. 35.62 for 1 packet(s) (10 ML eye drop each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition for OCUNAP

Naphazoline(NA),Chlorpheniramine(NA)

food interaction for OCUNAP

alcohol interaction for OCUNAP

pregnancy interaction for OCUNAP

lactation interaction for OCUNAP

food
alcohol
pregnancy
lactation
There is no data available. Please consult doctor before consuming the drug.
Ocunap eye drop may cause excessive drowsiness and calmness with alcohol.
UNSAFE
Ocunap eye drop may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
WEIGH RISKS VS. BENEFITS
Unknown. Human and animal studies are not available. Please consult your doctor.

SALT INFORMATION for OCUNAP

Naphazoline(NA)

Uses

Naphazoline is used in the treatment of rhinitis (common cold) and conjunctivitis.

How it works

Naphazoline nitrate belongs to a class of medication called alpha 2 agonist. It works by temporarily narrowing swollen blood vessels and reduces swelling of mucous membrane in the nose to relieve congestion or irritation.

Common side effects

Blurred vision, Headache, Increased intraocular pressure, Dilation of the pupil of the eye, Tingling sensation
Chlorpheniramine(NA)

Uses

Chlorpheniramine is used in the treatment of allergic disorders.

How it works

Chlorpheniramine belongs to class of medications called antihistamines. It acts by blocking a natural chemical (histamine) that your body makes during an allergic reaction. Histamine is responsible for many symptoms of allergy. 

Common side effects

Nausea, Constipation, Drowsiness, Dry mouth, Dry throat, Dry skin, Headache, Inability to empty the urinary bladder, Loss of appetite, Nasal congestion, Chest congestion, Vomiting

SUBSTITUTES for OCUNAP

No substitutes found

Expert advice for OCUNAP

• Seek medical advice if the symptoms persist or worsen after 3 days of treatment.
• Avoid prolonged use of medication as it may affect normal mucosal layer of nose and can cause loss of sensation of smell. 
• Seek immediate medical attention if you experience chest pain, fast/ irregular heart beat; severe headache, sweating, blurred vision, ringing in ears, anxiety, confusion, or breathlessness.
• Tell your doctor if you are or planning to become pregnant or are breastfeeding.
• Should not be given to patients allergic to naphazoline nasal or any of its ingredients.
• Should not be given to children < 12 years
• Should not be given to patients with heart disease, diabetes, depression, disorders related to thyroid glands.
• Should not be given to patients with high blood pressure and taking medication for the same.

Frequently asked questions for OCUNAP

Naphazoline

Q.Is Naphazoline safe?
Naphazoline is safe if taken at prescribed dose and duration as advised by your doctor.

Chlorpheniramine

Q.Does chlorpheniramine or chlorpheniramine maleate cause increase in blood pressure/ drowsy/non drowsy/sedating/get you high/keep you awake/sleepiness/make you tired/weight gain?
Chlorpheniramine causing these side effects is common or rare. Always consult your doctor, if you experience any of these side effects

Q.Is chlorpheniramine like Benadryl?
No, chlorpheniramine is different from Benadryl

Q.Is chlorpheniramine prescription?
Yes, it is available with doctor’s prescription only

Q.Can I take chlorpheniramine or chlorpheniramine maleate with Panadol/ cetirizine /Zyrtec/ Allegra/ warfarin/ diphenhydramine/ ibuprofen/Claritin/guaifenesin/Benadryl?
Yes, but taking other medicines may alter the effects of chlorpheniramine. Always consult your doctor for the change of dose regimen or an alternative drug of choice that may strictly be required

Q.Does chlorpheniramine contain aspirin?
No, it does not contain aspirin in it. Chlorpheniramine is a different drug than aspirin.

Articles


Content on this page was last updated on 19 November, 2014, by Dr. Varun Gupta (MD Pharmacology)